Eli Lilly Breaks Ground on $3.5B Manufacturing Facility in Pennsylvania

  • Eli Lilly has broken ground on a $3.5 billion manufacturing facility in Fogelsville, Pennsylvania, to expand production capacity for injectable medicines, including its investigational obesity treatment retatrutide.
  • The site is expected to create 850 high-wage jobs and approximately 2,000 construction jobs, with operations targeted to begin by 2031.

Eli Lilly and Company has broken ground on a $3.5 billion manufacturing facility in Pennsylvania’s Lehigh Valley, expanding its U.S. production capacity for injectable medicines and devices. Located in Fogelsville, the facility will support the production of next-generation obesity treatments, including retatrutide, an investigational triple hormone receptor agonist targeting GIP, GLP-1 and glucagon. The site is expected to become operational by 2031.

The investment is part of Lilly’s $50 billion commitment to expand medicine production in the United States. It is one of 10 new U.S. manufacturing sites announced by the company since 2020 and one of four dedicated to injectable medicines and devices. Lilly CEO David A. Ricks said the facility would help the company manufacture next-generation medicines for patients in the United States and around the world.

The facility will use machine learning, artificial intelligence, digitally integrated systems and advanced data analytics. Digital automation will be embedded throughout the site to support production processes and right-first-time execution. According to Lilly, each production run currently involves more than 5,000 documented steps, while each unit is imaged and inspected more than 70 times to check for defects. The new facility will build on these quality control processes through advanced automation and digital systems.

Lilly expects the facility to create 850 high-wage jobs, including roles for engineers, scientists, operations personnel and laboratory technicians. Approximately 2,000 construction jobs are also expected as the site is built and brought online. The company is currently hiring in the Lehigh Valley.

As part of its community commitment, Lilly will provide up to $1 million over five years to the Upper Macungie Township Community Fund to support a proposed quality-of-life program for local families. The initiative is expected to focus on nutrition, healthy living, fresh food access, health resources and community programming. The facility is also targeting LEED Gold certification as part of the company’s environmental stewardship commitments.

CDMO News Analysed

The latest CDMO investments, partnerships, and market intelligence.

Real-time news analysis

  • Full tracker of partnerships and strategic announcements.
  • Deal value of disclosed investment
  • Regional and modality trends

Fill out the form below for immediate access: